Rising demand for minimally invasive surgical procedures is expected to drive the growth of the surgical power tools market. Minimally invasive surgeries offer benefits such as faster recovery times, reduced risk of infection, and smaller incisions, leading to increased adoption among patients and healthcare providers.
Advancements in technology, such as the development of robotic-assisted surgical systems, are also fueling growth in the market. These technologies enable surgeons to perform complex procedures with greater precision and control, leading to improved patient outcomes.
The growing prevalence of chronic diseases and the aging population are further driving the demand for surgical power tools. As the incidence of conditions such as cardiovascular disease and cancer continues to rise, the need for surgical interventions is expected to increase, driving market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, End-use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | DePuy Synthes, Orthopromed, B Braun, CONMED, Zimmer Biomet, Stryker, KLS Martin Group, Medtronic |
Stringent regulatory requirements surrounding the use of surgical power tools pose a major challenge for market players. Manufacturers must navigate complex regulatory landscapes to ensure compliance with standards set by regulatory bodies, which can be time-consuming and costly.
The high cost of surgical power tools and accessories is also a significant restraint in the market. The initial investment required to purchase these tools, as well as the ongoing maintenance and replacement costs, can be prohibitive for some healthcare facilities, particularly in emerging markets.